Skip to content

Weekday Japan business intelligence for finance professionals.

Join the list
Tokyo Brief東 京 ブ リ ー フJapan's day, wrapped and delivered by morning.
Company
Companies

TSE 4530

久光製薬

4530 · TSE · Pharmaceutical

Financials Consolidated

Revenue¥156bn+10.1% year on yearConsolidated · FY2/25

Ordinary profit¥24.0bn+22.2% year on yearConsolidated · FY2/25

Net profit¥21.8bn+55.8% year on yearConsolidated · FY2/25

Dividend per share¥90.00FY2/25

Performance over time

Revenue
¥115bnFY2/21
¥120bnFY2/22
¥128bnFY2/23
¥142bnFY2/24
¥156bnFY2/25
Ordinary profit
¥11.8bnFY2/21
¥12.6bnFY2/22
¥16.1bnFY2/23
¥19.6bnFY2/24
¥24.0bnFY2/25
Net profit (attributable)
¥9.25bnFY2/21
¥9.66bnFY2/22
¥11.7bnFY2/23
¥14.0bnFY2/24
¥21.8bnFY2/25
Op. cash flow
¥5.29bnFY2/21
¥19.2bnFY2/22
¥12.7bnFY2/23
¥18.2bnFY2/24
¥18.8bnFY2/25

People & pay

Employees, whole group2,799 peopleFY2/25

Employees, parent company (non-consolidated)1,488 peopleFY2/25

Average salary¥7.53mFY2/25

Average salary is for the parent company's own employees (non-consolidated), as Japanese annual reports disclose it.

Five-year history
Five-year history
Fiscal yearRevenueOrdinary profitNet profit (attributable)EPSDividendTotal assetsNet assetsOp. cash flow
FY2/25¥156bn+10.1% year on year¥24.0bn¥21.76bn¥295.57¥90.00¥343bn¥279bn¥18.77bn
FY2/24¥142bn+10.4% year on year¥19.6bn¥13.97bn¥181.62¥85.00¥329bn¥267bn¥18.19bn
FY2/23¥128bn+6.8% year on year¥16.1bn¥11.74bn¥148.01¥84.50¥314bn¥258bn¥12.73bn
FY2/22¥120bn+5.0% year on year¥12.6bn¥9.66bn¥118.92¥84.00¥303bn¥255bn¥19.20bn
FY2/21¥115bn¥11.8bn¥9.25bn¥113.22¥83.50¥300bn¥254bn¥5.29bn

Per-share figures are as each report states them: a share split is restated only for the year before it, and dividends are as paid.

Figures from annual report S100VT69 · Japan GAAP. Each figure's years come from one report's five-year summary.